Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes?
| Data(s) |
2006
|
|---|---|
| Identificador | |
| Publicador |
Informa Healthcare |
| Relação |
DOI:10.1517/14656566.7.9.1229 Doggrell, Sheila (2006) Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(9), pp. 1229-1233. |
| Palavras-Chave | #060100 BIOCHEMISTRY AND CELL BIOLOGY #060500 MICROBIOLOGY #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES |
| Tipo |
Journal Article |
